Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin G Sanda

Showing results (131-140 of 180) with videos related to

Pageof 18
Sort By:
BMC Medical Informatics and Decision Making|January 11, 2019
Assigning value to preparation for prostate cancer decision making: a willingness to pay analysisLeslie S Wilson, Traci M Blonquist, Fangxin Hong, et al.
Theranostics|May 17, 2021
A panel of selected serum protein biomarkers for the detection of aggressive prostate cancerJin Song, Shiyong Ma, Lori J Sokoll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2013
Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance StudyDaniel W Lin, Lisa F Newcomb, Elissa C Brown, et al.
Cancer|March 4, 2025
Utilization, health care expenditures, and patient costs of definitive treatment modalities for localized prostate cancer in the United StatesNikhil T Sebastian, Dattatraya Patil, Pretesh R Patel, et al.
Nature|October 11, 2002
The polycomb group protein EZH2 is involved in progression of prostate cancerSooryanarayana Varambally, Saravana M Dhanasekaran, Ming Zhou, et al.
Nature|November 7, 2024
Author Correction: Differentiation fate of a stem-like CD4 T cell controls immunity to cancerMaria A Cardenas, Nataliya Prokhnevska, Ewelina Sobierajska, et al.
Nature|October 24, 2024
Differentiation fate of a stem-like CD4 T cell controls immunity to cancerMaria A Cardenas, Nataliya Prokhnevska, Ewelina Sobierajska, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2013
Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experienceDaniel A Hamstra, Anna S C Conlon, Stephanie Daignault, et al.
The New England Journal of Medicine|September 24, 2005
Autoantibody signatures in prostate cancerXiaoju Wang, Jianjun Yu, Arun Sreekumar, et al.
Nature Genetics|July 21, 2025
NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodelingXiaodong Lu, Viriya Keo, Irina Cheng, et al.
Pageof 18

Showing results (131-140 of 180) with videos related to

Sort By:
Pageof 18
BMC Medical Informatics and Decision Making|January 11, 2019
Assigning value to preparation for prostate cancer decision making: a willingness to pay analysisLeslie S Wilson, Traci M Blonquist, Fangxin Hong, et al.
Theranostics|May 17, 2021
A panel of selected serum protein biomarkers for the detection of aggressive prostate cancerJin Song, Shiyong Ma, Lori J Sokoll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2013
Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance StudyDaniel W Lin, Lisa F Newcomb, Elissa C Brown, et al.
Cancer|March 4, 2025
Utilization, health care expenditures, and patient costs of definitive treatment modalities for localized prostate cancer in the United StatesNikhil T Sebastian, Dattatraya Patil, Pretesh R Patel, et al.
Nature|October 11, 2002
The polycomb group protein EZH2 is involved in progression of prostate cancerSooryanarayana Varambally, Saravana M Dhanasekaran, Ming Zhou, et al.
Nature|November 7, 2024
Author Correction: Differentiation fate of a stem-like CD4 T cell controls immunity to cancerMaria A Cardenas, Nataliya Prokhnevska, Ewelina Sobierajska, et al.
Nature|October 24, 2024
Differentiation fate of a stem-like CD4 T cell controls immunity to cancerMaria A Cardenas, Nataliya Prokhnevska, Ewelina Sobierajska, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2013
Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experienceDaniel A Hamstra, Anna S C Conlon, Stephanie Daignault, et al.
The New England Journal of Medicine|September 24, 2005
Autoantibody signatures in prostate cancerXiaoju Wang, Jianjun Yu, Arun Sreekumar, et al.
Nature Genetics|July 21, 2025
NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodelingXiaodong Lu, Viriya Keo, Irina Cheng, et al.
Pageof 18